The development of a new active ingredient takes about 10 years, a significant part of which consists of clinical trials. Hungary’s role is outstanding in the field of clinical trials in Europe: several companies engaged in pharmaceutical innovation have established their Central-Eastern European clinical research centres in Hungary. 

The clinical trials for pharmaceutical development performed in Hungary add around 100 billion HUF value annually to the Hungarian economy and provide a new chance for about 20,000 Hungarian patients every year for recovery or the improvement of their quality of life, making state-of-the-art treatments available to them free of charge.

Are you interested in clinical trials? 

The development of a new active ingredient takes about 10 years, a significant part of which consists of clinical trials. Hungary’s role is outstanding in the field of clinical trials in Europe: several companies engaged in pharmaceutical innovation have established their Central-Eastern European clinical research centres in Hungary. 

The clinical trials for pharmaceutical development performed in Hungary add around 100 billion HUF value annually to the Hungarian economy and provide a new chance for about 20,000 Hungarian patients every year for recovery or the improvement of their quality of life, making state-of-the-art treatments available to them free of charge.

Are you interested in clinical trials?